{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:08:14Z","timestamp":1793833694444,"version":"4.6.1"},"reference-count":89,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T00:00:00Z","timestamp":1739404800000},"content-version":"unspecified","delay-in-days":12,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"crossref","award":["INV-038215"],"award-info":[{"award-number":["INV-038215"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Glob Health"],"accepted":{"date-parts":[[2024,12,28]]},"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Globally, tuberculosis (TB) remains one of the leading infectious causes of death, with 1.3\u2009million deaths. Digital adherence technologies (DATs) have the potential to provide person-centred care and improve outcomes. Using the reach, effectiveness, adoption, implementation and maintenance (RE-AIM) framework, we conducted a scoping review of DAT implementations for TB treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We searched seven databases for papers published between January 2000 and April 2023, using keywords for \u2018tuberculosis\u2019 and \u2018digital adherence technology\u2019. Articles meeting prespecified inclusion criteria and containing data on RE-AIM domains were included. We defined \u2018reach\u2019 as comprising cellphone ownership and engagement by people with TB (PWTB) with DATs, \u2018adoption\u2019 as engagement by healthcare providers with DAT programmes, \u2018implementation\u2019 as the fidelity of the DAT programme implemented and \u2018maintenance\u2019 as longer-term uptake of DATs.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 10\u2009313 records, 102 contributed to the synthesis. DATs included short message service (SMS), phone, 99DOTS, video-supported therapy (VST) and pillboxes. For \u2018reach\u2019, across various settings, cellphone access varied from 50%\u2013100% and 2%\u201331% of PWTB was excluded from accessing DATs due to technology challenges. 36%\u2013100% of PWTB agreed to use a DAT. The weighted mean of DAT engagement over dose-days was 81% for SMS, 85% for phone, 61% for 99DOTS, 87% for pillbox and 82% for VST. Concerning \u2018implementation\u2019, the fidelity of DAT implementations was affected by technological issues such as cellphone coverage, DAT malfunction and provider-facing issues, including failure to initiate intensified patient management following low DAT engagement. Findings related to RE-AIM dimensions of \u2018adoption\u2019 and \u2018maintenance\u2019 were limited.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our findings suggest that the \u2018reach\u2019 of DATs may be limited by a cascade of barriers, including limitations in cellphone accessibility and suboptimal sustained DAT engagement by PWTB. Video and pillbox DATs have higher levels of engagement. Implementation challenges included technological and provider-facing issues. Improving implementation outcomes may be important for TB DATs to achieve a broader public health impact.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD42022326968<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjgh-2024-016535","type":"journal-article","created":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T13:05:15Z","timestamp":1739451915000},"page":"e016535","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":16,"title":["Implementation outcomes of tuberculosis digital adherence technologies: a scoping review using the RE-AIM framework"],"prefix":"10.1136","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9039-2367","authenticated-orcid":false,"given":"Chimweta I","family":"Chilala","sequence":"first","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4630-6243","authenticated-orcid":false,"given":"Nicola","family":"Foster","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shruti","family":"Bahukudumbi","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona Salaheldin","family":"Mohamed","sequence":"additional","affiliation":[{"name":"McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda","family":"Zary","sequence":"additional","affiliation":[{"name":"McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Kafie","sequence":"additional","affiliation":[{"name":"McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbie","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1072-2683","authenticated-orcid":false,"given":"Genevieve","family":"Gore","sequence":"additional","affiliation":[{"name":"McGill Schulich Library of Physical Sciences, Life Sciences and Engineering, McGill University, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3354-1159","authenticated-orcid":false,"given":"Kevin","family":"Schwartzman","sequence":"additional","affiliation":[{"name":"McGill International Tuberculosis Centre, Research Institute of the McGill University Health Centre, Montreal, Quebec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-943X","authenticated-orcid":false,"given":"Ramnath","family":"Subbaraman","sequence":"additional","affiliation":[{"name":"Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston, Massachusetts, USA"},{"name":"Division of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6524-3754","authenticated-orcid":false,"given":"Katherine L","family":"Fielding","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology, London School of Hygiene & Tropical Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,2,13]]},"reference":[{"key":"2025073015245470000_10.2.e016535.1","unstructured":"Available: https:\/\/www.who.int\/teams\/global-tuberculosis-programme\/tb-reports\/global-tuberculosis-report-2024"},{"key":"2025073015245470000_10.2.e016535.2","unstructured":"World Health Organization . What is DOTS? a guide to understanding the WHO-recommended tb control strategy known as DOTS. Switzerland World Health Organisation; 1999. Available: https:\/\/iris.who.int\/bitstream\/handle\/10665\/65979\/WHO_CDS_CPC_TB_99.270.pdf"},{"key":"2025073015245470000_10.2.e016535.3","unstructured":"World Health Organisation . Consolidated guidelines on tuberculosis. module 4: treatment. Switzerland: World Health Organisation; 2022. Available: https:\/\/www.who.int\/publications\/i\/item\/9789240048126"},{"key":"2025073015245470000_10.2.e016535.4","unstructured":"World Health Organisation . Adherence to long-term therapies: evidence for action. World Health Organisation; 2003. Available: https:\/\/www.paho.org\/en\/documents\/who-adherence-long-term-therapies-evidence-action-2003"},{"key":"2025073015245470000_10.2.e016535.5","doi-asserted-by":"crossref","DOI":"10.2196\/33062","article-title":"Digital Health Technologies to Improve Medication Adherence and Treatment Outcomes in Patients With Tuberculosis: Systematic Review of Randomized Controlled Trials","volume":"24","author":"Ridho","year":"2022","journal-title":"J Med Internet Res"},{"key":"2025073015245470000_10.2.e016535.6","doi-asserted-by":"crossref","unstructured":"Mohamed MS , Zary M , Kafie C , et al . The impact of digital adherence technologies on health outcomes in tuberculosis: a systematic review and meta-analysis. [Preprint] 2024. doi:10.1101\/2024.01.31.24302115","DOI":"10.1101\/2024.01.31.24302115"},{"key":"2025073015245470000_10.2.e016535.7","doi-asserted-by":"crossref","DOI":"10.1017\/cts.2021.789","article-title":"Understanding and applying the RE-AIM framework: Clarifications and resources","volume":"5","author":"Holtrop","year":"2021","journal-title":"J Clin Transl Sci"},{"key":"2025073015245470000_10.2.e016535.8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-016608","article-title":"Contextual factors influencing implementation of tuberculosis digital adherence technologies: a scoping review guided by the re-aim framework","volume":"10","author":"Bahukudumbi","year":"2024","journal-title":"BMJ global health"},{"key":"2025073015245470000_10.2.e016535.9","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"2025073015245470000_10.2.e016535.10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(23)02270-5","article-title":"Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multicentre randomised controlled trial","volume":"403","author":"Wei","year":"2024","journal-title":"The Lancet"},{"key":"2025073015245470000_10.2.e016535.11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid Based Healthc"},{"key":"2025073015245470000_10.2.e016535.12","doi-asserted-by":"crossref","first-page":"103550","DOI":"10.1016\/j.ajp.2023.103550","article-title":"Beyond the funnel plot: The advantages of Doi plots and prediction intervals in meta-analyses","volume":"84","author":"Shamim","year":"2023","journal-title":"Asian J Psychiatr"},{"key":"2025073015245470000_10.2.e016535.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2014.03.003"},{"key":"2025073015245470000_10.2.e016535.14","doi-asserted-by":"crossref","unstructured":"Guzman K , Crowder R , Leddy A , et al . Acceptability and feasibility of digital adherence technologies for tuberculosis treatment supervision: a meta-analysis of implementation feedback. Infectious Diseases (except HIV\/AIDS) [Preprint] 2023. doi:10.1101\/2023.01.26.23284950","DOI":"10.1101\/2023.01.26.23284950"},{"key":"2025073015245470000_10.2.e016535.15","doi-asserted-by":"crossref","DOI":"10.3390\/tropicalmed7050065","article-title":"Time Trend Analysis of Tuberculosis Treatment While Using Digital Adherence Technologies-An Individual Patient Data Meta-Analysis of Eleven Projects across Ten High Tuberculosis-Burden Countries","volume":"7","author":"de Groot","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"2025073015245470000_10.2.e016535.16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001876","article-title":"Effectiveness of Electronic Reminders to Improve Medication Adherence in Tuberculosis Patients: A Cluster-Randomised Trial","volume":"12","author":"Liu","year":"2015","journal-title":"PLoS Med"},{"key":"2025073015245470000_10.2.e016535.17","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-019-4521-2","article-title":"Using electronic medication monitoring to guide differential management of tuberculosis patients at the community level in China","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Infect Dis"},{"key":"2025073015245470000_10.2.e016535.18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232337","article-title":"Electronic medication monitor for people with tuberculosis: Implementation experience from thirty counties in China","volume":"15","author":"Wang","year":"2020","journal-title":"PLoS ONE"},{"key":"2025073015245470000_10.2.e016535.19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003628","article-title":"Digital adherence technology for tuberculosis treatment supervision: A stepped-wedge cluster-randomized trial in Uganda","volume":"18","author":"Cattamanchi","year":"2021","journal-title":"PLoS Med"},{"key":"2025073015245470000_10.2.e016535.20","doi-asserted-by":"crossref","first-page":"e1901","DOI":"10.1093\/cid\/ciaa1557","article-title":"Electronic Dose Monitoring Identifies a High-Risk Subpopulation in the Treatment of Drug-resistant Tuberculosis and Human Immunodeficiency Virus","volume":"73","author":"Zelnick","year":"2021","journal-title":"Clin Infect Dis"},{"key":"2025073015245470000_10.2.e016535.21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.5588\/ijtld.21.0632","article-title":"Feasibility and acceptability of asynchronous VOT among patients with MDR-TB","volume":"26","author":"Casalme","year":"2022","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073015245470000_10.2.e016535.22","doi-asserted-by":"crossref","unstructured":"Cross A , Gupta N , Liu B , et al . 99DOTS: a low-cost approach to monitoring and improving medication adherence. 10th International Conference on Information and Communication Technologies and Development (ICTD); 2019 doi:10.1145\/3287098.3287102","DOI":"10.1145\/3287098.3287102"},{"key":"2025073015245470000_10.2.e016535.23","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000003082"},{"key":"2025073015245470000_10.2.e016535.24","doi-asserted-by":"publisher","DOI":"10.1258\/jtt.2012.120311"},{"key":"2025073015245470000_10.2.e016535.25","doi-asserted-by":"crossref","first-page":"e693","DOI":"10.1016\/S2214-109X(23)00068-2","article-title":"Digital adherence technologies to improve tuberculosis treatment outcomes in China: a cluster-randomised superiority trial","volume":"11","author":"Liu","year":"2023","journal-title":"Lancet Glob Health"},{"key":"2025073015245470000_10.2.e016535.26","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/QAI.0000000000002940","article-title":"Bedaquiline Adherence Measured by Electronic Dose Monitoring Predicts Clinical Outcomes in the Treatment of Patients With Multidrug-Resistant Tuberculosis and HIV\/AIDS","volume":"90","author":"O\u2019Donnell","year":"2022","journal-title":"J Acquir Immune Defic Syndr"},{"key":"2025073015245470000_10.2.e016535.27","doi-asserted-by":"crossref","unstructured":"Chen AZ , Kumar R , Baria RK , et al . Impact of the 99DOTS digital adherence technology on tuberculosis treatment outcomes in North India: a pre-post study. In Review [Preprint] 2022. doi:10.21203\/rs.3.rs-1900171\/v1","DOI":"10.21203\/rs.3.rs-1900171\/v1"},{"key":"2025073015245470000_10.2.e016535.28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0050155","article-title":"Home videophones improve direct observation in tuberculosis treatment: a mixed methods evaluation","volume":"7","author":"Wade","year":"2012","journal-title":"PLoS One"},{"key":"2025073015245470000_10.2.e016535.29","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2147\/PPA.S135540","article-title":"Text messaging to decrease tuberculosis treatment attrition in TB-HIV coinfection in Uganda","volume":"11","author":"Hermans","year":"2017","journal-title":"Patient Prefer Adherence"},{"key":"2025073015245470000_10.2.e016535.30","doi-asserted-by":"publisher","DOI":"10.3233\/SHTI200387"},{"key":"2025073015245470000_10.2.e016535.31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0162944","article-title":"Impact of a Daily SMS Medication Reminder System on Tuberculosis Treatment Outcomes: A Randomized Controlled Trial","volume":"11","author":"Mohammed","year":"2016","journal-title":"PLoS ONE"},{"key":"2025073015245470000_10.2.e016535.32","doi-asserted-by":"publisher","DOI":"10.1097\/QAI.0000000000001025"},{"key":"2025073015245470000_10.2.e016535.33","doi-asserted-by":"crossref","DOI":"10.1136\/bmjhci-2020-100268","article-title":"Effect of a phone reminder system on patient-centered tuberculosis treatment adherence among adults in Northwest Ethiopia: a randomised controlled trial","volume":"28","author":"Gashu","year":"2021","journal-title":"BMJ Health Care Inform"},{"key":"2025073015245470000_10.2.e016535.34","doi-asserted-by":"crossref","unstructured":"Kiwanuka N , Kityamuwesi A , Crowder R , et al . Implementation, feasibility, and acceptability of 99DOTS-based supervision of treatment for drug-susceptible TB in Uganda. Infectious Diseases (except HIV\/AIDS) [Preprint] 2022. doi:10.1101\/2022.10.10.22280911","DOI":"10.1101\/2022.10.10.22280911"},{"key":"2025073015245470000_10.2.e016535.35","unstructured":"Efo E , Onjare B , Shilugu L . Acceptability, feasibility and accuracy of 99dots adherence technology in mining region of tanzania. IST-Africa Conference (IST-Africa); 2021."},{"key":"2025073015245470000_10.2.e016535.36","doi-asserted-by":"publisher","DOI":"10.1007\/s10461-015-1254-0"},{"key":"2025073015245470000_10.2.e016535.37","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0373"},{"key":"2025073015245470000_10.2.e016535.38","first-page":"551","article-title":"Factors associated with treatment adherence in a randomised trial of latent tuberculosis infection treatment","volume":"14","author":"Trajman","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073015245470000_10.2.e016535.39","doi-asserted-by":"crossref","unstructured":"Bendiksen R , Ovesen T , Asfeldt A-M , et al . Use of video directly observed treatment for tuberculosis in Northern Norway. Tidsskr Nor Laegeforen 2020;140. doi:10.4045\/tidsskr.19.0322","DOI":"10.4045\/tidsskr.19.0322"},{"key":"2025073015245470000_10.2.e016535.40","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.15.0738"},{"key":"2025073015245470000_10.2.e016535.41","doi-asserted-by":"publisher","DOI":"10.3201\/eid2410.180459"},{"key":"2025073015245470000_10.2.e016535.42","doi-asserted-by":"crossref","first-page":"00175","DOI":"10.1183\/23120541.00175-2019","article-title":"Video directly observed therapy for supporting and monitoring adherence to tuberculosis treatment in Uganda: a pilot cohort study","volume":"6","author":"Sekandi","year":"2020","journal-title":"ERJ Open Res"},{"key":"2025073015245470000_10.2.e016535.43","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2010.02.018"},{"key":"2025073015245470000_10.2.e016535.44","doi-asserted-by":"crossref","DOI":"10.2196\/17658","article-title":"A Comprehensive App That Improves Tuberculosis Treatment Management Through Video-Observed Therapy: Usability Study","volume":"8","author":"Guo","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"key":"2025073015245470000_10.2.e016535.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2017.09.029"},{"key":"2025073015245470000_10.2.e016535.46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.5588\/ijtld.19.0183","article-title":"An assessment of current tuberculosis patient care and support policies in high-burden countries","volume":"24","author":"Cocozza","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073015245470000_10.2.e016535.47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/PHH.0000000000000627","article-title":"A National Survey on the Use of Electronic Directly Observed Therapy for Treatment of Tuberculosis","volume":"24","author":"Macaraig","year":"2018","journal-title":"J Public Health Manag Pract"},{"key":"2025073015245470000_10.2.e016535.48","doi-asserted-by":"crossref","DOI":"10.1186\/s40249-021-00818-3","article-title":"Effect of using electronic medication monitors on tuberculosis treatment outcomes in China: a longitudinal ecological study","volume":"10","author":"Wang","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"2025073015245470000_10.2.e016535.49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001018","article-title":"Digital adherence technologies for the management of tuberculosis therapy: mapping the landscape and research priorities","volume":"3","author":"Subbaraman","year":"2018","journal-title":"BMJ Glob Health"},{"key":"2025073015245470000_10.2.e016535.50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2024-015633","article-title":"The performance of digital technologies for measuring tuberculosis medication adherence: a systematic review","volume":"9","author":"Zary","year":"2024","journal-title":"BMJ Glob Health"},{"key":"2025073015245470000_10.2.e016535.51","doi-asserted-by":"publisher","DOI":"10.1111\/tmi.13087"},{"key":"2025073015245470000_10.2.e016535.52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-010512","article-title":"Can digital adherence technologies reduce inequity in tuberculosis treatment success? Evidence from a randomised controlled trial","volume":"7","author":"Boutilier","year":"2022","journal-title":"BMJ Glob Health"},{"key":"2025073015245470000_10.2.e016535.53","doi-asserted-by":"crossref","DOI":"10.1186\/s12874-021-01381-z","article-title":"Conducting proportional meta-analysis in different types of systematic reviews: a guide for synthesisers of evidence","volume":"21","author":"Barker","year":"2021","journal-title":"BMC Med Res Methodol"},{"key":"2025073015245470000_10.2.e016535.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12961-023-01054-x","article-title":"Barriers and facilitators of implementing electronic monitors to improve adherence and health outcomes in tuberculosis patients: protocol for a systematic review based on the Consolidated Framework for Implementation Research","volume":"21","author":"Li","year":"2023","journal-title":"Health Res Policy Syst"},{"key":"2025073015245470000_10.2.e016535.55","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-023-10361-6","article-title":"Optimising the implementation of digital-supported interventions for the secondary prevention of heart disease: a systematic review using the RE-AIM planning and evaluation framework","volume":"23","author":"de Moel-Mandel","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"2025073015245470000_10.2.e016535.56","doi-asserted-by":"publisher","DOI":"10.1093\/jamia\/ocaa041"},{"key":"2025073015245470000_10.2.e016535.57","unstructured":"Higgins JPT , Thomas J , Chandler J , et al . Cochrane handbook for systematic reviews of interventions . Chichester, UK: John Wiley & Sons, 2023."},{"key":"2025073015245470000_10.2.e016535.58","doi-asserted-by":"publisher","DOI":"10.7326\/M17-1150"},{"key":"2025073015245470000_10.2.e016535.59","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s10461-016-1432-8","article-title":"A Qualitative Evaluation of the Acceptability of an Interactive Voice Response System to Enhance Adherence to Isoniazid Preventive Therapy Among People Living with HIV in Ethiopia","volume":"21","author":"Daftary","year":"2017","journal-title":"AIDS Behav"},{"key":"2025073015245470000_10.2.e016535.60","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01488-2017"},{"key":"2025073015245470000_10.2.e016535.61","article-title":"Patient-centered mobile tuberculosis treatment support tools (TB-TSTs) to improve treatment adherence: A pilot randomized controlled trial exploring feasibility, acceptability and refinement needs","volume":"13","author":"Iribarren","year":"2022","journal-title":"Lancet Reg Health Am"},{"key":"2025073015245470000_10.2.e016535.62","doi-asserted-by":"crossref","first-page":"321","DOI":"10.2147\/PPA.S321289","article-title":"Evaluation of Mobile Application for the Management of Tuberculosis Patients in Tianjin During 2019-2020","volume":"16","author":"Li","year":"2022","journal-title":"Patient Prefer Adherence"},{"key":"2025073015245470000_10.2.e016535.63","doi-asserted-by":"publisher","DOI":"10.4103\/lungindia.lungindia_86_18"},{"key":"2025073015245470000_10.2.e016535.64","doi-asserted-by":"publisher","DOI":"10.1177\/1054773808316941"},{"key":"2025073015245470000_10.2.e016535.65","doi-asserted-by":"crossref","unstructured":"Guo G , Sun L , Wushoue Q , et al . eDOTS: a new system applied for improving the treatment of pulmonary tuberculosis patients from Kashgar villages and Urumqi streets in Xinjiang, China. In Review [Preprint] 2021. doi:10.21203\/rs.3.rs-279235\/v1","DOI":"10.21203\/rs.3.rs-279235\/v1"},{"key":"2025073015245470000_10.2.e016535.66","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-022-02521-y","article-title":"Effectiveness of a digital medication event reminder and monitor device for patients with tuberculosis (SELFTB): a multicenter randomized controlled trial","volume":"20","author":"Manyazewal","year":"2022","journal-title":"BMC Med"},{"key":"2025073015245470000_10.2.e016535.67","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16030412","article-title":"Medication Event Monitoring System for Infectious Tuberculosis Treatment in Morocco: A Retrospective Cohort Study","volume":"16","author":"Park","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"2025073015245470000_10.2.e016535.68","doi-asserted-by":"publisher","DOI":"10.2471\/BLT.11.086462"},{"key":"2025073015245470000_10.2.e016535.69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.5588\/ijtld.22.0500","article-title":"The effect of medication event reminder monitoring on treatment adherence of TB patients","volume":"27","author":"Velen","year":"2023","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073015245470000_10.2.e016535.70","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.10.0210"},{"key":"2025073015245470000_10.2.e016535.71","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/S0140-6736(18)32993-3","article-title":"Smartphone-enabled video-observed versus directly observed treatment for tuberculosis: a multicentre, analyst-blinded, randomised, controlled superiority trial","volume":"393","author":"Story","year":"2019","journal-title":"Lancet"},{"key":"2025073015245470000_10.2.e016535.72","doi-asserted-by":"crossref","DOI":"10.2196\/38247","article-title":"Programmatic Adoption and Implementation of Video-Observed Therapy in Minnesota: Prospective Observational Cohort Study","volume":"6","author":"Bachina","year":"2022","journal-title":"JMIR Form Res"},{"key":"2025073015245470000_10.2.e016535.73","doi-asserted-by":"publisher","DOI":"10.1086\/324506"},{"key":"2025073015245470000_10.2.e016535.74","doi-asserted-by":"crossref","first-page":"520","DOI":"10.5588\/ijtld.19.0456","article-title":"Evaluation of recorded video-observed therapy for anti-tuberculosis treatment","volume":"24","author":"Garfein","year":"2020","journal-title":"Int J Tuberc Lung Dis"},{"key":"2025073015245470000_10.2.e016535.75","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.14.0923"},{"key":"2025073015245470000_10.2.e016535.76","doi-asserted-by":"crossref","DOI":"10.2196\/13411","article-title":"Use of Smartphone-Based Video Directly Observed Therapy (vDOT) in Tuberculosis Care: Single-Arm, Prospective Feasibility Study","volume":"3","author":"Holzman","year":"2019","journal-title":"JMIR Form Res"},{"key":"2025073015245470000_10.2.e016535.77","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofy046","article-title":"Advancing Patient-Centered Care in Tuberculosis Management: A Mixed-Methods Appraisal of Video Directly Observed Therapy","volume":"5","author":"Holzman","year":"2018","journal-title":"Open Forum Infect Dis"},{"key":"2025073015245470000_10.2.e016535.78","doi-asserted-by":"crossref","DOI":"10.2196\/35994","article-title":"Video-Observed Therapy With a Notification System for Improving the Monitoring of Tuberculosis Treatment in Thailand: Usability Study","volume":"6","author":"Kumwichar","year":"2022","journal-title":"JMIR Form Res"},{"key":"2025073015245470000_10.2.e016535.79","doi-asserted-by":"crossref","DOI":"10.2196\/jmir.9825","article-title":"Using Video Technology to Increase Treatment Completion for Patients With Latent Tuberculosis Infection on 3-Month Isoniazid and Rifapentine: An Implementation Study","volume":"20","author":"Lam","year":"2018","journal-title":"J Med Internet Res"},{"key":"2025073015245470000_10.2.e016535.80","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-022-07787-4","article-title":"Tuberculosis treatment adherence in the era of COVID-19","volume":"22","author":"Lippincott","year":"2022","journal-title":"BMC Infect Dis"},{"key":"2025073015245470000_10.2.e016535.81","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00011015"},{"key":"2025073015245470000_10.2.e016535.82","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.15585\/mmwr.mm6650a5","article-title":"Notes from the Field: Use of Asynchronous Video Directly Observed Therapy for Treatment of Tuberculosis and Latent Tuberculosis Infection in a Long-Term-Care Facility - Puerto Rico, 2016-2017","volume":"66","author":"Olano-Soler","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2025073015245470000_10.2.e016535.83","doi-asserted-by":"publisher","DOI":"10.5588\/ijtld.21.0170"},{"key":"2025073015245470000_10.2.e016535.84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1080\/23744235.2022.2160492","article-title":"Asynchronous video supported treatment of tuberculosis is well adopted in a real-world setting - an observational study comparing two distinct applications","volume":"55","author":"Rajalahti","year":"2023","journal-title":"Infect Dis (Lond)"},{"key":"2025073015245470000_10.2.e016535.85","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3390\/tropicalmed7020026","article-title":"Telehealth Reduces Missed Appointments in Pediatric Patients with Tuberculosis Infection","volume":"7","author":"Zhao","year":"2022","journal-title":"TropicalMed"},{"key":"2025073015245470000_10.2.e016535.86","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002891","article-title":"Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial","volume":"16","author":"Browne","year":"2019","journal-title":"PLoS Med"},{"key":"2025073015245470000_10.2.e016535.87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274112","article-title":"Design, development, and testing of a voice-text mobile health application to support Tuberculosis medication adherence in Uganda","volume":"17","author":"Katende","year":"2022","journal-title":"PLoS ONE"},{"key":"2025073015245470000_10.2.e016535.88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053373","article-title":"Feasibility of an ingestible sensor-based system for monitoring adherence to tuberculosis therapy","volume":"8","author":"Belknap","year":"2013","journal-title":"PLoS ONE"},{"key":"2025073015245470000_10.2.e016535.89","doi-asserted-by":"crossref","unstructured":"Wei X , Hicks JP , Zhang Z , et al . Effectiveness of a comprehensive package based on electronic medication monitors at improving treatment outcomes among tuberculosis patients in Tibet: a multi-centre randomised controlled trial. SSRN [Preprint] 2023. doi:10.2139\/ssrn.4387313","DOI":"10.2139\/ssrn.4387313"}],"container-title":["BMJ Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjgh-2024-016535","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T22:25:13Z","timestamp":1753914313000},"score":1,"resource":{"primary":{"URL":"https:\/\/gh.bmj.com\/lookup\/doi\/10.1136\/bmjgh-2024-016535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":89,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,13]]},"published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10.1136\/bmjgh-2024-016535"],"URL":"https:\/\/doi.org\/10.1136\/bmjgh-2024-016535","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.06.11.24308660","asserted-by":"object"}]},"ISSN":["2059-7908"],"issn-type":[{"value":"2059-7908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2]]}}}